2-N-(5-piperazin-1-yl-2-pyridinyl)-6-N-[6-(trifluoromethyl)-3-pyridinyl]-3H-imidazo[4,5-c]pyridine-2,6-diamine
C21H20F3N9 — CID 155566213
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-N-(5-piperazin-1-yl-2-pyridinyl)-6-N-[6-(trifluoromethyl)-3-pyridinyl]-3H-imidazo[4,5-c]pyridine-2,6-diamine
2-N-(5-piperazin-1-yl-2-pyridinyl)-6-N-[6-(trifluoromethyl)-3-pyridinyl]-3H-imidazo[4,5-c]pyridine-2,6-diamine (PubChem CID 155566213) has the molecular formula C21H20F3N9 and a molecular weight of 455.45 g/mol. Its IUPAC name is 2-N-(5-piperazin-1-yl-2-pyridinyl)-6-N-[6-(trifluoromethyl)-3-pyridinyl]-3H-imidazo[4,5-c]pyridine-2,6-diamine.
Molecular Properties
| Compound Name | 2-N-(5-piperazin-1-yl-2-pyridinyl)-6-N-[6-(trifluoromethyl)-3-pyridinyl]-3H-imidazo[4,5-c]pyridine-2,6-diamine |
|---|---|
| PubChem CID | 155566213 |
| Molecular Formula | C21H20F3N9 |
| Molecular Weight | 455.45 g/mol |
| Exact Mass | 455.18 |
| IUPAC Name | 2-N-(5-piperazin-1-yl-2-pyridinyl)-6-N-[6-(trifluoromethyl)-3-pyridinyl]-3H-imidazo[4,5-c]pyridine-2,6-diamine |
| SMILES | FC(F)(F)c1ccc(Nc2cc3nc(Nc4ccc(N5CCNCC5)cn4)[nH]c3cn2)cn1 |
| InChI | InChI=1S/C21H20F3N9/c22-21(23,24)17-3-1-13(10-26-17)29-19-9-15-16(12-28-19)31-20(30-15)32-18-4-2-14(11-27-18)33-7-5-25-6-8-33/h1-4,9-12,25H,5-8H2,(H,28,29)(H2,27,30,31,32) |
| InChIKey | SKSDYESPNVIOQN-UHFFFAOYSA-N |
| XLogP | 3.66 |
| TPSA | 106.68 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 33 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 455.45 |
| LogP ≤ 5 | 3.66 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155566213 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.